SANSIMEON, INC
Medtech
Integrated automated platform for reproducible single-cell sequencing sample preparation and cell encapsulation from clinical specimens
- Grants
- $2.0M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · A Uniquely Scalable Approach to Sequence Tens of Millions of Single Cells Without Compromising Performance | $275,628 | |
| Federal grant | Department of Health and Human Services · Phase I · A Uniquely Scalable Approach to Single Cell Sequencing for the Development of Next Generation Cell Therapies | $399,369 | |
| Federal grant | Department of Health and Human Services · Phase II · A Uniquely Scalable Platform for Sequencing Tens of Millions of Single Cells from Complex Clinical Samples with a Streamlined Workflow | $938,335 | |
| Federal grant | Department of Health and Human Services · Phase II · A Fully Integrated Platform for Reproducible and Scalable Single-Cell Sequencing in Clinical Research | $382,798 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1704 | PYRAMES INC | — | — |
| 1705 | SEABIRD LIFESCIENCES LLC | — | — |
| 1706 | KASA BIO, L.L.C. | — | — |
| 1707 | SANSIMEON, INC | — | — |
| 1708 | NEPHSMART LLC | — | — |
| 1709 | ZENALUX BIOMEDICAL, INC. | — | — |
| 1710 | AIGENE, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.